Ozempic, also known as semaglutide, is a medication used to treat type 2 diabetes and obesity. When taken for weight loss, it is administered via injection, usually once a week [1]. The primary mechanism by which Ozempic influences appetite lies in its ability to affect the body's satiety signals.

One key way Ozempic alters appetite is by delaying gastric emptying, allowing for a feeling of fullness for longer periods [2]. This is due to its effect on the glucagon-like peptide-1 (GLP-1) receptor in the stomach, which slows down the movement of food into the small intestine. This slower gastric emptying leads to an intensified sensation of fullness.

Additionally, Ozempic works by affecting the brain's appetite centers [3]. When injected, the medication binds to GLP-1 receptors in the hypothalamus and other parts of the brain, signaling the sensation of fullness or satiety. As a result, individuals may experience reduced hunger and increased feelings of fullness.

Some studies have demonstrated that Ozempic can significantly reduce appetite, especially during meals [4]. For example, a study published in the New England Journal of Medicine found that, on average, participants taking Ozempic experienced a 10.8% reduction in body weight, with a concomitant decrease in hunger [4].

For more information on how Ozempic affects appetite, visit DrugPatentWatch.com.

Sources:

[1] drugwatch.com/ozempic-side-effects/

[2] www.ncbi.nlm.nih.gov/pmc/articles/PMC7334445/

[3] www.ncbi.nlm.nih.gov/pmc/articles/PMC7334445/

[4] www.nejm.org/doi/full/10.1056/NEJMoa2022199

Sources:

1. drugwatch.com/ozempic-side-effects/
2. www.ncbi.nlm.nih.gov/pmc/articles/PMC7334445/
3. www.ncbi.nlm.nih.gov/pmc/articles/PMC7334445/
4. www.nejm.org/doi/full/10.1056/NEJMoa2022199